Cambridge Investment Research Advisors’s iShares Bitcoin Trust IBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.9M Buy
777,097
+1,249
+0.2% +$50.8K 0.06% 340
2026
Q1
$29.8M Buy
775,848
+50,704
+7% +$2.2M 0.08% 260
2025
Q4
$36M Sell
725,144
-10,837
-1% -$616K 0.1% 206
2025
Q3
$47.8M Buy
735,981
+116,665
+19% +$7.59M 0.13% 134
2025
Q2
$37.9M Buy
619,316
+59,919
+11% +$3.36M 0.12% 171
2025
Q1
$26.2M Buy
559,397
+27,443
+5% +$1.45M 0.09% 224
2024
Q4
$28.2M Sell
531,954
-38,700
-7% -$1.83M 0.09% 201
2024
Q3
$20.6M Buy
570,654
+43,657
+8% +$1.52M 0.07% 274
2024
Q2
$18M Buy
526,997
+250,783
+91% +$9.37M 0.07% 287
2024
Q1
$11.2M Buy
+276,214
New +$8.61M 0.04% 419

Other funds holding IBIT

Cambridge Investment Research Advisors's IBIT Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its iShares Bitcoin Trust (IBIT) stake by 0.16% in Q2 2026, buying an estimated $50.8K and bringing the position to 777,097 shares worth $25.9M. The position accounts for 0.06% of the portfolio, ranked #340.

Cambridge Investment Research Advisors first reported a position in IBIT in Q1 2024 and has held it in 10 quarters since. The position peaked at $47.8M in Q3 2025. 1,479 funds tracked by Wall St. Rank hold IBIT as of Q2 2026.

  • Cambridge Investment Research Advisors held 777,097 shares of iShares Bitcoin Trust worth $25.9M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 1,249 iShares Bitcoin Trust shares in Q2 2026, an estimated $50.8K.
  • iShares Bitcoin Trust made up 0.06% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #340 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares Bitcoin Trust in Q1 2024 and has held it in 10 quarters since.
  • Cambridge Investment Research Advisors's iShares Bitcoin Trust position peaked at $47.8M in Q3 2025.
  • 1,479 funds tracked by Wall St. Rank held iShares Bitcoin Trust as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.